Human Igg Subclass Rid Kit

FDA 510(k) K915650 · Janssen Biochimica

Substantially Equivalent

510(k) numberK915650

Submission

Device name
Human Igg Subclass Rid Kit
Applicant
Janssen Biochimica
Piscataway, NJ, US
Received
December 18, 1991
Decision date
March 26, 1992
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) statement available from FDA

Official FDA 510(k) record

Device classification

Product code
CGM – Method, Immunodiffusion, Immunoglobulins (G, A, M)
Device class
Class II (moderate risk)
Regulation
21 CFR 866.5510
Specialty
Immunology

Other 510(k)s with product code CGM

510(k)DeviceApplicantDecision
K920006Il Test Immunoglobulin G (Igg)CGM · Traditional Instrumentation Laboratory CO03/13/1992SE
K920370Isotypes Human Igg Subclass Eia KitCGM · Traditional Isotypes, Inc.03/11/1992SE
K920008Il Test Immunoglobulin M (Igm)CGM · Traditional Instrumentation Laboratory CO03/11/1992SE

Questions and answers

When was Human Igg Subclass Rid Kit cleared by the FDA?

Human Igg Subclass Rid Kit (K915650) received a 510(k) decision of Substantially Equivalent on March 26, 1992, 99 days after the submission was received.

What is the product code of K915650?

The FDA product code is CGM – Method, Immunodiffusion, Immunoglobulins (G, A, M), a Class II (moderate risk) device regulated under 21 CFR 866.5510.